PT3554474T - Composições de micafungina - Google Patents

Composições de micafungina

Info

Publication number
PT3554474T
PT3554474T PT178294120T PT17829412T PT3554474T PT 3554474 T PT3554474 T PT 3554474T PT 178294120 T PT178294120 T PT 178294120T PT 17829412 T PT17829412 T PT 17829412T PT 3554474 T PT3554474 T PT 3554474T
Authority
PT
Portugal
Prior art keywords
micafungin
compositions
micafungin compositions
Prior art date
Application number
PT178294120T
Other languages
English (en)
Original Assignee
Baxter Healthcare Sa
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare Sa, Baxter Int filed Critical Baxter Healthcare Sa
Publication of PT3554474T publication Critical patent/PT3554474T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT178294120T 2016-12-16 2017-12-15 Composições de micafungina PT3554474T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662435695P 2016-12-16 2016-12-16

Publications (1)

Publication Number Publication Date
PT3554474T true PT3554474T (pt) 2024-02-12

Family

ID=60972375

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178294120T PT3554474T (pt) 2016-12-16 2017-12-15 Composições de micafungina

Country Status (11)

Country Link
US (1) US20180169180A1 (pt)
EP (1) EP3554474B1 (pt)
JP (2) JP2020510619A (pt)
AU (1) AU2017376960B2 (pt)
DK (1) DK3554474T3 (pt)
ES (1) ES2972008T3 (pt)
FI (1) FI3554474T3 (pt)
HU (1) HUE066069T2 (pt)
PL (1) PL3554474T3 (pt)
PT (1) PT3554474T (pt)
WO (1) WO2018112330A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111044636A (zh) * 2019-12-30 2020-04-21 卓和药业集团有限公司 米卡芬净含量的分析方法
US20220040092A1 (en) * 2020-06-27 2022-02-10 RK Pharma Solutions LLC Ready to use injectable formulations of Micafungin Sodium
CN112710753A (zh) * 2020-12-18 2021-04-27 卓和药业集团有限公司 米卡芬净有关物质的分析方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849843A (en) 1993-11-16 1998-12-15 Baxter International Inc. Polymeric compositions for medical packaging and devices
US5998019A (en) 1993-11-16 1999-12-07 Baxter International Inc. Multi-layered polymer structure for medical products
TWI233805B (en) 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6991800B2 (en) * 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
US20110071072A1 (en) * 2009-08-28 2011-03-24 Georgetown University, A Congressionally Chartered Institution Of Higher Education Antifungal Bone Cements
CN102614492B (zh) * 2011-01-31 2013-12-11 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物
CN102775476B (zh) * 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
CN102512379B (zh) * 2011-12-16 2017-03-08 深圳市健元医药科技有限公司 一种新型棘白菌素类抗真菌药物组合物及其制备方法
WO2016107890A1 (en) * 2014-12-31 2016-07-07 Galenicum Health S.L. Stable pharmaceutical compositions comprising micafungin
AU2016334826B2 (en) * 2015-10-07 2020-08-27 Sumitomo Pharma Co., Ltd. Pyrimidine compound
WO2017060923A1 (en) * 2015-10-10 2017-04-13 Gufic Biosciences Limited Freeze dried parenteral formulation of micafungin sodium and to process thereof

Also Published As

Publication number Publication date
ES2972008T3 (es) 2024-06-10
HUE066069T2 (hu) 2024-07-28
JP2020510619A (ja) 2020-04-09
AU2017376960B2 (en) 2023-12-14
PL3554474T3 (pl) 2024-04-15
JP2024012211A (ja) 2024-01-25
EP3554474B1 (en) 2023-12-06
DK3554474T3 (da) 2024-02-19
AU2017376960A1 (en) 2019-05-23
EP3554474A1 (en) 2019-10-23
FI3554474T3 (fi) 2024-02-21
WO2018112330A1 (en) 2018-06-21
US20180169180A1 (en) 2018-06-21

Similar Documents

Publication Publication Date Title
HRP20210342T8 (hr) Pripravci glikopeptida
IL261792B (en) Preparations
IL260933A (en) Preparations containing tocorsol or its analogues
SG11201705415YA (en) Multi-supplement compositions
IL257131A (en) Preparations
GB201610156D0 (en) Cliptac compositions
HK1251559A1 (zh) 普那布林組合物
GB201501598D0 (en) Compositions
GB201515387D0 (en) Compositions
GB201515391D0 (en) Compositions
SI3349766T1 (sl) Antihemoragični sestavki
GB201614799D0 (en) Compositions
PL3058958T3 (pl) Kompozycja anidulafunginy
PT3554474T (pt) Composições de micafungina
GB201622161D0 (en) Compositions
GB2538335B (en) Compositions
PL3393503T3 (pl) Kompozycje
GB201602658D0 (en) Compositions
GB201614230D0 (en) Compositions
GB201611960D0 (en) Compositions
GB201611851D0 (en) Compositions
GB201602656D0 (en) Compositions
GB201522892D0 (en) Compositions
GB201511469D0 (en) Compositions
GB201507673D0 (en) Compositions